Project Umbrella Translation
No. 02 BSAA
Following Raccoon City's destruction, Umbrella was dealt a crippling blow when many lawsuits were filed to investigate its criminal liability. There was however an organization that suffered more damage than Umbrella. It was the "Pharmaceutical Industry Association", a trade group with pharmaceutical companies from all over the world among its members.
The revelation that Umbrella had been developing, testing and distributing "Bio Organic Weapons (B.O.W.)" on the black market undermined trust in the entire pharmaceutical industry, compounded by the fact Umbrella itself was one of the Pharmaceutical Industry Association's executive board companies.
If that had been all, they might've gotten off with only a sullied image. In the present age, drugs and medical treatment are inseparable.
There are times people won't be bothered by image in order to use a drug.
As the lawsuits progressed however, the situation started to shift.
The names of various pharmaceutical companies began appearing in the evidence presented by the prosecution.
Umbrella had ingeniously incorporated chemicals and technologies developed by numerous pharmaceutical companies into all aspects of weapons development.
If this were everything it wouldn't have mattered, but they outsourced some development to those pharmaceutical companies and devised it in such a way they'd be unaware it was for biological weapons development. From the pharmaceutical companies' perspective, it meant they were unknowingly complicit in developing bioweapons.
Up until this point, some of the association's corporate members had regarded the Umbrella problem as a minor issue.
But it was a different story once these companies were defendants themselves.
They were about to be held liable for an incident that killed 100,000 people.
If they lost the lawsuit, continuation for the companies was hopeless.
Even if they were acquitted, the deterioration of their image would have a massive influence on not only their sales, but also authorizations from governments around the world. For pharmaceutical companies, not receiving approval for drugs they develop also functions as a death sentence.
This forced the Pharmaceutical Industry Association's corporate members to take action against this.
The Pharmaceutical Industry Association offered the prosecution a plea bargain. The association said it would fully cooperate in solving the case with an offer to provide any trade secrets to corner Umbrella.
Hell-bent on bringing down Umbrella, the prosecution favorably accepted this suggestion, shelving prosecution of the companies within the Pharmaceutical Industry Association.
Then in 2003, it was declared that Umbrella had comprehensively lost the case. Umbrella collapsed and it appeared as though the giant scandal, poised to embroil the entire pharmaceutical industry, would be over.
However, the situation began to take an unexpected turn.
B.O.W.'s began leaking onto black markets around the world due to Umbrella's collapse.
Since they ended up in the hands of certain nations, guerrillas and terrorists, the threat of B.O.W.'s even rained down upon the general public. This forced the Pharmaceutical Industry Association to take further action.
This led to the formation of the anti-bioterrorism unit "BSAA (Bioterrorism Security Assessment Alliance)".
The BSAA initially consisted of only eleven elite members, limited to being deployed as observers on anti-bioterror ops by the armed forces and law enforcement agencies of various nations.
However, the onslaught of bioterror far exceeded expectations and it soon became impossible to respond to it through such methods.
For that reason, although the BSAA was a civilian-led organization, there were considerations for the formation of a service unit capable of rapidly responding to situations.
Moreover, foreign government-led nations naturally had limitations on investigations, arrests, and associated use of force.
The bioterror threat was already becoming a global problem however.
Accordingly, the BSAA was restructured as an anti-bioterror unit under the jurisdiction of the United Nations.
As a special operations unit under UN jurisdiction, it's safe to say the UN member nations were ready to accept them, to some degree.
In fact, in the resolution pertaining to the BSAA's formation, 70% of the member nations allowed the BSAA to operate on their soil, while the remaining countries permitted it to operate albeit with some restrictions.
The BSAA as we know it today was thus born.
BSAA Headquarters is located in the United Kingdom, but its precise location isn't publicly disclosed.
Since BSAA units are capable of deploying within 12 hours to any area within their jurisdiction, they're believed to be based near airport hubs or air force bases.
It's also said that within the same branch, there may be multiple bases within its jurisdiction.
The jurisdictions of each BSAA branch are as follows.
European Headquarters
→Europe region, including western Russia region
Middle East Branch
→Middle East region, including part of the African continent
North America Branch
→Whole North American continent (Chris Redfield belongs)
South America Branch
→Whole of South America
West Africa Branch
→Western part of the African continent (Sheva Alomar belongs)
East Africa Branch
→Eastern part of the African continent
Far East Branch
→Asian region and the Far East Russian region east of India
Oceania Branch (※)
→Oceania region with a focus on Australia
※The Antarctic Continent where the Umbrella Antarctic Laboratory was located is under the jurisdiction of the Oceania Branch.
The BSAA employs a considerable amount of service units in each branch, mostly comprised of individuals experienced in the special ops of various nation's law enforcement agencies and armed forces.
In addition, it's reported that a substantial number of active personnel from various countries' governmental organizations are temporarily transferred as support staff for the field service units.
There are technical members in the service units, and many groups of experts are among the personnel who provide technical, medical, physical, and mental support to the teams.
BSAA service units are divided between two major types.
Firstly, members who belong to a team called the "Special Operations Unit."
They act in team formations and are professionals in infiltration, combat and suppression.
The basic organization of the squad structure formation is twelve people divided into three groups by four.
A feature of the SOU is in the flexible activities of its personnel.
Depending on an operation's scale, a unit team can be merged with another team, and in certain joint ops, more than 70 elites of each branch participated in those ops.
In this op, Dan DeChant leads the Alpha Team, and the team formation's mixed between a quick team of DeChant's conventional subordinates, and a group of another team.
(The name Alpha Team is a moniker to be used only in this op)
Such unique military unit implementation could be said to be the result of considering strong points of operational aspects in previously unheard of anti-bioweapon combat, over existing formation methods and traditionally managed military unit formations.
The others are "Special Operations Agents."
They're usually simply referred to as agents.
While SOU operate in teams, agents operate individually.
The main duties of agents are investigation and espionage, making them the eyes of the BSAA in a sense.
In addition, when the nature of an op doesn't allow for troops to be deployed, agents may engage in the op.
In such cases, the minimum unit for executing a mission is two agents, in two-man cells.
Additionally, among agents, there are also some engaged in ops outside their own branches.
Most are agents tracking illegal activities taking place in multiple regions, Chris Redfield being one such person on this mission.
Since agents have the ability to act independently, they're often seen as being of a higher rank than SOU members, but they're actually selected based more on their psychology and aptitude over their abilities or skills. If they were to be compared it therefore wouldn't be unusual to find that SOU members are superior in terms of individual skill alone.
In these manners, the BSAA is a public organization possessing multinational military unit-like elements, but it's a widely known fact most of its operational funding comes from the Pharmaceutical Industry Association due to the circumstances of its formation. Although this situation's often a target of criticism, it has yet to improve since without their funding, it would impose a substantial financial burden on the member nations.
On top of that, since the Pharmaceutical Industry Association considers its investment in the BSAA critical to promoting the industry's overall standing, this relationship's expected to continue for the foreseeable future.
Finally, the eleven members who belonged to the BSAA since its inception are respectfully known as the "Original Eleven" among the unit. This originates from the seven astronauts chosen in the U.S. Mercury Project, who were dubbed the Original Seven. Chris Redfield's also among the Original Eleven, with several of those members still active among the teams.
Following Raccoon City's destruction, Umbrella was dealt a crippling blow when many lawsuits were filed to investigate its criminal liability. There was however an organization that suffered more damage than Umbrella. It was the "Pharmaceutical Industry Association", a trade group with pharmaceutical companies from all over the world among its members.
The revelation that Umbrella had been developing, testing and distributing "Bio Organic Weapons (B.O.W.)" on the black market undermined trust in the entire pharmaceutical industry, compounded by the fact Umbrella itself was one of the Pharmaceutical Industry Association's executive board companies.
If that had been all, they might've gotten off with only a sullied image. In the present age, drugs and medical treatment are inseparable.
There are times people won't be bothered by image in order to use a drug.
As the lawsuits progressed however, the situation started to shift.
The names of various pharmaceutical companies began appearing in the evidence presented by the prosecution.
Umbrella had ingeniously incorporated chemicals and technologies developed by numerous pharmaceutical companies into all aspects of weapons development.
If this were everything it wouldn't have mattered, but they outsourced some development to those pharmaceutical companies and devised it in such a way they'd be unaware it was for biological weapons development. From the pharmaceutical companies' perspective, it meant they were unknowingly complicit in developing bioweapons.
Up until this point, some of the association's corporate members had regarded the Umbrella problem as a minor issue.
But it was a different story once these companies were defendants themselves.
They were about to be held liable for an incident that killed 100,000 people.
If they lost the lawsuit, continuation for the companies was hopeless.
Even if they were acquitted, the deterioration of their image would have a massive influence on not only their sales, but also authorizations from governments around the world. For pharmaceutical companies, not receiving approval for drugs they develop also functions as a death sentence.
This forced the Pharmaceutical Industry Association's corporate members to take action against this.
The Pharmaceutical Industry Association offered the prosecution a plea bargain. The association said it would fully cooperate in solving the case with an offer to provide any trade secrets to corner Umbrella.
Hell-bent on bringing down Umbrella, the prosecution favorably accepted this suggestion, shelving prosecution of the companies within the Pharmaceutical Industry Association.
Then in 2003, it was declared that Umbrella had comprehensively lost the case. Umbrella collapsed and it appeared as though the giant scandal, poised to embroil the entire pharmaceutical industry, would be over.
However, the situation began to take an unexpected turn.
B.O.W.'s began leaking onto black markets around the world due to Umbrella's collapse.
Since they ended up in the hands of certain nations, guerrillas and terrorists, the threat of B.O.W.'s even rained down upon the general public. This forced the Pharmaceutical Industry Association to take further action.
This led to the formation of the anti-bioterrorism unit "BSAA (Bioterrorism Security Assessment Alliance)".
The BSAA initially consisted of only eleven elite members, limited to being deployed as observers on anti-bioterror ops by the armed forces and law enforcement agencies of various nations.
However, the onslaught of bioterror far exceeded expectations and it soon became impossible to respond to it through such methods.
For that reason, although the BSAA was a civilian-led organization, there were considerations for the formation of a service unit capable of rapidly responding to situations.
Moreover, foreign government-led nations naturally had limitations on investigations, arrests, and associated use of force.
The bioterror threat was already becoming a global problem however.
Accordingly, the BSAA was restructured as an anti-bioterror unit under the jurisdiction of the United Nations.
As a special operations unit under UN jurisdiction, it's safe to say the UN member nations were ready to accept them, to some degree.
In fact, in the resolution pertaining to the BSAA's formation, 70% of the member nations allowed the BSAA to operate on their soil, while the remaining countries permitted it to operate albeit with some restrictions.
The BSAA as we know it today was thus born.
BSAA Headquarters is located in the United Kingdom, but its precise location isn't publicly disclosed.
Since BSAA units are capable of deploying within 12 hours to any area within their jurisdiction, they're believed to be based near airport hubs or air force bases.
It's also said that within the same branch, there may be multiple bases within its jurisdiction.
The jurisdictions of each BSAA branch are as follows.
European Headquarters
→Europe region, including western Russia region
Middle East Branch
→Middle East region, including part of the African continent
North America Branch
→Whole North American continent (Chris Redfield belongs)
South America Branch
→Whole of South America
West Africa Branch
→Western part of the African continent (Sheva Alomar belongs)
East Africa Branch
→Eastern part of the African continent
Far East Branch
→Asian region and the Far East Russian region east of India
Oceania Branch (※)
→Oceania region with a focus on Australia
※The Antarctic Continent where the Umbrella Antarctic Laboratory was located is under the jurisdiction of the Oceania Branch.
The BSAA employs a considerable amount of service units in each branch, mostly comprised of individuals experienced in the special ops of various nation's law enforcement agencies and armed forces.
In addition, it's reported that a substantial number of active personnel from various countries' governmental organizations are temporarily transferred as support staff for the field service units.
There are technical members in the service units, and many groups of experts are among the personnel who provide technical, medical, physical, and mental support to the teams.
BSAA service units are divided between two major types.
Firstly, members who belong to a team called the "Special Operations Unit."
They act in team formations and are professionals in infiltration, combat and suppression.
The basic organization of the squad structure formation is twelve people divided into three groups by four.
A feature of the SOU is in the flexible activities of its personnel.
Depending on an operation's scale, a unit team can be merged with another team, and in certain joint ops, more than 70 elites of each branch participated in those ops.
In this op, Dan DeChant leads the Alpha Team, and the team formation's mixed between a quick team of DeChant's conventional subordinates, and a group of another team.
(The name Alpha Team is a moniker to be used only in this op)
Such unique military unit implementation could be said to be the result of considering strong points of operational aspects in previously unheard of anti-bioweapon combat, over existing formation methods and traditionally managed military unit formations.
The others are "Special Operations Agents."
They're usually simply referred to as agents.
While SOU operate in teams, agents operate individually.
The main duties of agents are investigation and espionage, making them the eyes of the BSAA in a sense.
In addition, when the nature of an op doesn't allow for troops to be deployed, agents may engage in the op.
In such cases, the minimum unit for executing a mission is two agents, in two-man cells.
Additionally, among agents, there are also some engaged in ops outside their own branches.
Most are agents tracking illegal activities taking place in multiple regions, Chris Redfield being one such person on this mission.
Since agents have the ability to act independently, they're often seen as being of a higher rank than SOU members, but they're actually selected based more on their psychology and aptitude over their abilities or skills. If they were to be compared it therefore wouldn't be unusual to find that SOU members are superior in terms of individual skill alone.
In these manners, the BSAA is a public organization possessing multinational military unit-like elements, but it's a widely known fact most of its operational funding comes from the Pharmaceutical Industry Association due to the circumstances of its formation. Although this situation's often a target of criticism, it has yet to improve since without their funding, it would impose a substantial financial burden on the member nations.
On top of that, since the Pharmaceutical Industry Association considers its investment in the BSAA critical to promoting the industry's overall standing, this relationship's expected to continue for the foreseeable future.
Finally, the eleven members who belonged to the BSAA since its inception are respectfully known as the "Original Eleven" among the unit. This originates from the seven astronauts chosen in the U.S. Mercury Project, who were dubbed the Original Seven. Chris Redfield's also among the Original Eleven, with several of those members still active among the teams.
Official Japanese Transcript
No. 02 BSAA
ラクーンシティ消滅後、その責任を追及するために提訴された数多くの訴訟はアンブレラに大打撃を与えた。だが、アンブレラ以上にダメージを負った団体があった。それが全世界の製薬企業が加盟する業界団体「製薬企業連盟」である。
アンブレラが「有機生命体兵器（B.O.W.)」の開発と実験、そして闇市場への流通を行っていたと言うことは、製薬業界全体の信頼を貶め、さらにはアンブレラ自体が製薬企業連盟の理事企業の一つであったこともそれに拍車をかけた。
それだけであればイメージの悪化だけで済んだかもしれない。現代では、薬と医療は不可分である。
必要とあれば、薬を使用するのにイメージなど気にしていられない場合もある。
だが、訴訟が進むにつれ状況が変化しはじめた。
検察側から提出された証拠に、様々な製薬企業の名前が登場し始めたのだ。
アンブレラは、各製薬企業が開発した薬品や技術を、兵器開発のあらゆる局面で巧みに取り入れていた。
それだけならまだしも、開発の一部を生物兵器開発のそれと悟らせないように、各製薬企業へと開発を委託していたのだ。各製薬企業からすれば、知らず知らずのうちに生物兵器開発に加担していたことになる。
これまで連盟の加盟企業の中でも、アンブレラ問題は対岸の火事と見る向きもあった。
しかし、ー転、被告企業となれば話は違ってくる。
何十万人が死亡した事件の責任を背負わされようとしているのだ。
敗訴となれば、会社の存続は絶望的。
例え無罪となったとしても、そのイメージ失墜は売り上げだけではなく、各国政府の許認可にも大きな影響を与えるだろう。製薬企業にとって、開発した薬が認可されないのは死刑宣告も同じである。
これには製薬企業連盟の加盟各社も、対抗措置を取らざるを得なかった。
製薬企業連盟は、検察側に司法取引を持ちかけた。連盟は今回の事件解決に全面的に協力し、アンブレラを追い詰めるためにはどんな企業機密も喜んで提供すると告げた。
この提案はアンブレラ壊滅に執念を燃やす検察側に好意的に受け入れられ、製薬企業連盟各社への起訴は見送られることとなった。
そして2003年、アンブレラの全面的敗訴が決定した。アンブレラは崩壊し、製薬業界全体を巻き込もうとしていたー大スキャンダルは終息するかと思われた。
だが、事態は予想外の展開を見せ始めた。
アンブレラの崩壊により、B.O.W.が世界中の闇市場へ流出し始めたのだ。
それらが一部の国家、ゲリラ、テロリストたちの手に渡ったため、B.O.W.の脅威が一般の人々にまで降り注ぐようになった。このため製薬企業連盟は、更なる対抗措置を取らざるを得なかった。
そこで組織されたのが、対バイオテロ部隊「BSAA (Bioterrorism Security Assessment Alliance)」である。
BSAAは、当初11名の精鋭のみで組織され、各国軍隊、警察の対バイオテロ作戦へ、オブザーバーを派遣するにとどまって いた。
しかし、バイオテロの猛威は予想をはるかにうわまわっており、そのような方法ではすぐに対処しきれなくなってしまった。
そのため、事態への即応が可能な実働部隊結成が検討され始めたが、BSAAはあくまで民間主導の組織である。
政府が存在する他国での捜査、逮捕、それに伴う武力行使には、おのずと限界が生じる。
だが、バイオテロの脅威は、すでに全世界的な問題となりつつあった。
そこでBSAAは、国連管轄の対バイオテロ部隊として再編成されることとなった。
国連管轄の特殊部隊であれば、国連加盟国ではある程度受け入れの素地が整っていると言っていい。
事実、BSAA結成に関する決議では、加盟国の7割が国内でのBSAAの活動を認め、残りの国も制限付きながら活動を認めるに至った。
こうして、現在のBSAAが誕生した。
BSAA本部はイギリスにあるが、詳しい所在地は非公開である。
BSAAの部隊は、管轄内の地域であれば12時間以内に部隊を展開させることが可能であるため、ハブ空港、もしくは空軍 基地の近くにその拠点を構えていると考えられる。
また、同一支部内でも管轄地域内にいくつかの拠点が存在すると言われている。
BSAA各支部の管轄地域は、以下のようになっている。
欧州本部
→西部ロシア地域を含む欧州地域
中東支部
→アフリカ大陸の一部を含む中東地域
北米支部
→北米大陸全域（クリス-レッドフィールドが所属)
南米支部
→南米大陸全域
西部アフリカ支部
→アフリカ大陸西部（シヱバ-アローマが所属）
東部アフリカ支部
→アフリカ大陸東部
極東支部
→インド以東のアジア地域と極東ロシア地域
オセアニア支部
→オーストラリアを中心とするオセアニア地域
※アンブレラ南極研究所のあった南極大陸は、オセアニア支部の管轄となる。
BSAAは各支部に相当数の実働部隊を擁しており、その多くは各国警察の特殊部隊、軍隊の経験者により構成されている。
また、実働部隊のサポ一トスタッフとして、各国の政府組織から相当数の現役職員が出向しているとも言われている。
彼らもまた、実働部隊の隊員たちをテクニカル、メディカル、フィジカル、メンタルの各方面から支えるサポートのエキスパート集団である。
BSAAの実働部隊は、大きく2つの種類に分けられる。
まず、「特殊作戦部隊(=Special Operations Unit)」と呼ばれるチームと、そこに所属する隊員たち。
チーム編成で行動する彼らは、突入、交戦、鎮圧のプロフェッショナルである。
基本は12名の分隊規模の編成で、さらにその12名を4名ずつの3班に分けて行動することもある。
SOUの特徴は、その柔軟な人員の運用にある。
作戦規模に応じて別チームからの班単位の合流は日常的に行われており、ある合同作戦では、各支部の精鋭70名以上が作戦に参加したとする記録もある。
本作戦では、アルファチームをダン-デチャントが率いているが、そのチーム編成も従来のデチャントの部下と別チームの班を混成させた即製チームである。
(よって、アルファチームという呼び方も本作戦でのみ使用される呼称である）
このような特殊な部隊運用は、これまでにない対生物兵器戦闘においては既存の編成法だと対応しきれないという事情と、従来の部隊編成が持つ管理、運用面での長所を考慮した結果と言える。
もう1つが「特殊作戦要員(=Special Operations Agent)」である。
通常は、ただ単にエージェントと呼ばれる場合が多い。
チームで動くSOUに対して、エージェントは個人で動く。
エージェントは、捜査、諜報活動を主な任務としており、言わばBSAAの目として活躍する存在である。
また、作戦の性格上、表立って部隊が投入できない場合はエージェントが作戦に従事することもある。
その場合、作戦遂行の最小単位は2名、2マンセルが基本である。
なお、エージェントの中には支部を越えて作戦に従事する者もいる。
その多くは、複数地域で行われる非合法活動を追うエージェントであり、本作戦でのクリス·レッドフィールドもその一人である。
エージェントは単独で行動できる能力を有していることから、SOUの隊員よりも格上と見られることが多いが、実際には能力、技術よりも心理面、適性が大きく考慮された上で選抜される。よって、個々の能力だけを比較すればSOUの隊員の方が優秀であることも珍しくない。
このように、BSAAは多国籍部隊的な要素を持つ公的組織ではあるが、その結成の経緯から、活動資金の多くが製薬企業連盟から捻出されていることは広く知られた事実である。このような状態はしばしば批判の的とされるが、資金提供がなければ加盟国に多額の負担金を強いることになるため、事態の改善には至っていない。
また、製薬企業連盟にとってもBSAAに出資していることは業界全体の姿勢をアピールする上で重要と考えられているため、この関係は当分の間続くとみられている。
最後に、BSAA結成当初から所属していた11名は、隊内では敬意を持って「オリジナル·イレブン」と呼ばれている。これは、アメリカのマーキュリー計画で選抜された7名の宇宙飛行士がオリジナル-セブンと呼ばれたことに由来している。オリジナル·イレブンの中にはクリス·レッドフィールドも含まれており、現在も数名の隊員が同隊で活躍中である。
ラクーンシティ消滅後、その責任を追及するために提訴された数多くの訴訟はアンブレラに大打撃を与えた。だが、アンブレラ以上にダメージを負った団体があった。それが全世界の製薬企業が加盟する業界団体「製薬企業連盟」である。
アンブレラが「有機生命体兵器（B.O.W.)」の開発と実験、そして闇市場への流通を行っていたと言うことは、製薬業界全体の信頼を貶め、さらにはアンブレラ自体が製薬企業連盟の理事企業の一つであったこともそれに拍車をかけた。
それだけであればイメージの悪化だけで済んだかもしれない。現代では、薬と医療は不可分である。
必要とあれば、薬を使用するのにイメージなど気にしていられない場合もある。
だが、訴訟が進むにつれ状況が変化しはじめた。
検察側から提出された証拠に、様々な製薬企業の名前が登場し始めたのだ。
アンブレラは、各製薬企業が開発した薬品や技術を、兵器開発のあらゆる局面で巧みに取り入れていた。
それだけならまだしも、開発の一部を生物兵器開発のそれと悟らせないように、各製薬企業へと開発を委託していたのだ。各製薬企業からすれば、知らず知らずのうちに生物兵器開発に加担していたことになる。
これまで連盟の加盟企業の中でも、アンブレラ問題は対岸の火事と見る向きもあった。
しかし、ー転、被告企業となれば話は違ってくる。
何十万人が死亡した事件の責任を背負わされようとしているのだ。
敗訴となれば、会社の存続は絶望的。
例え無罪となったとしても、そのイメージ失墜は売り上げだけではなく、各国政府の許認可にも大きな影響を与えるだろう。製薬企業にとって、開発した薬が認可されないのは死刑宣告も同じである。
これには製薬企業連盟の加盟各社も、対抗措置を取らざるを得なかった。
製薬企業連盟は、検察側に司法取引を持ちかけた。連盟は今回の事件解決に全面的に協力し、アンブレラを追い詰めるためにはどんな企業機密も喜んで提供すると告げた。
この提案はアンブレラ壊滅に執念を燃やす検察側に好意的に受け入れられ、製薬企業連盟各社への起訴は見送られることとなった。
そして2003年、アンブレラの全面的敗訴が決定した。アンブレラは崩壊し、製薬業界全体を巻き込もうとしていたー大スキャンダルは終息するかと思われた。
だが、事態は予想外の展開を見せ始めた。
アンブレラの崩壊により、B.O.W.が世界中の闇市場へ流出し始めたのだ。
それらが一部の国家、ゲリラ、テロリストたちの手に渡ったため、B.O.W.の脅威が一般の人々にまで降り注ぐようになった。このため製薬企業連盟は、更なる対抗措置を取らざるを得なかった。
そこで組織されたのが、対バイオテロ部隊「BSAA (Bioterrorism Security Assessment Alliance)」である。
BSAAは、当初11名の精鋭のみで組織され、各国軍隊、警察の対バイオテロ作戦へ、オブザーバーを派遣するにとどまって いた。
しかし、バイオテロの猛威は予想をはるかにうわまわっており、そのような方法ではすぐに対処しきれなくなってしまった。
そのため、事態への即応が可能な実働部隊結成が検討され始めたが、BSAAはあくまで民間主導の組織である。
政府が存在する他国での捜査、逮捕、それに伴う武力行使には、おのずと限界が生じる。
だが、バイオテロの脅威は、すでに全世界的な問題となりつつあった。
そこでBSAAは、国連管轄の対バイオテロ部隊として再編成されることとなった。
国連管轄の特殊部隊であれば、国連加盟国ではある程度受け入れの素地が整っていると言っていい。
事実、BSAA結成に関する決議では、加盟国の7割が国内でのBSAAの活動を認め、残りの国も制限付きながら活動を認めるに至った。
こうして、現在のBSAAが誕生した。
BSAA本部はイギリスにあるが、詳しい所在地は非公開である。
BSAAの部隊は、管轄内の地域であれば12時間以内に部隊を展開させることが可能であるため、ハブ空港、もしくは空軍 基地の近くにその拠点を構えていると考えられる。
また、同一支部内でも管轄地域内にいくつかの拠点が存在すると言われている。
BSAA各支部の管轄地域は、以下のようになっている。
欧州本部
→西部ロシア地域を含む欧州地域
中東支部
→アフリカ大陸の一部を含む中東地域
北米支部
→北米大陸全域（クリス-レッドフィールドが所属)
南米支部
→南米大陸全域
西部アフリカ支部
→アフリカ大陸西部（シヱバ-アローマが所属）
東部アフリカ支部
→アフリカ大陸東部
極東支部
→インド以東のアジア地域と極東ロシア地域
オセアニア支部
→オーストラリアを中心とするオセアニア地域
※アンブレラ南極研究所のあった南極大陸は、オセアニア支部の管轄となる。
BSAAは各支部に相当数の実働部隊を擁しており、その多くは各国警察の特殊部隊、軍隊の経験者により構成されている。
また、実働部隊のサポ一トスタッフとして、各国の政府組織から相当数の現役職員が出向しているとも言われている。
彼らもまた、実働部隊の隊員たちをテクニカル、メディカル、フィジカル、メンタルの各方面から支えるサポートのエキスパート集団である。
BSAAの実働部隊は、大きく2つの種類に分けられる。
まず、「特殊作戦部隊(=Special Operations Unit)」と呼ばれるチームと、そこに所属する隊員たち。
チーム編成で行動する彼らは、突入、交戦、鎮圧のプロフェッショナルである。
基本は12名の分隊規模の編成で、さらにその12名を4名ずつの3班に分けて行動することもある。
SOUの特徴は、その柔軟な人員の運用にある。
作戦規模に応じて別チームからの班単位の合流は日常的に行われており、ある合同作戦では、各支部の精鋭70名以上が作戦に参加したとする記録もある。
本作戦では、アルファチームをダン-デチャントが率いているが、そのチーム編成も従来のデチャントの部下と別チームの班を混成させた即製チームである。
(よって、アルファチームという呼び方も本作戦でのみ使用される呼称である）
このような特殊な部隊運用は、これまでにない対生物兵器戦闘においては既存の編成法だと対応しきれないという事情と、従来の部隊編成が持つ管理、運用面での長所を考慮した結果と言える。
もう1つが「特殊作戦要員(=Special Operations Agent)」である。
通常は、ただ単にエージェントと呼ばれる場合が多い。
チームで動くSOUに対して、エージェントは個人で動く。
エージェントは、捜査、諜報活動を主な任務としており、言わばBSAAの目として活躍する存在である。
また、作戦の性格上、表立って部隊が投入できない場合はエージェントが作戦に従事することもある。
その場合、作戦遂行の最小単位は2名、2マンセルが基本である。
なお、エージェントの中には支部を越えて作戦に従事する者もいる。
その多くは、複数地域で行われる非合法活動を追うエージェントであり、本作戦でのクリス·レッドフィールドもその一人である。
エージェントは単独で行動できる能力を有していることから、SOUの隊員よりも格上と見られることが多いが、実際には能力、技術よりも心理面、適性が大きく考慮された上で選抜される。よって、個々の能力だけを比較すればSOUの隊員の方が優秀であることも珍しくない。
このように、BSAAは多国籍部隊的な要素を持つ公的組織ではあるが、その結成の経緯から、活動資金の多くが製薬企業連盟から捻出されていることは広く知られた事実である。このような状態はしばしば批判の的とされるが、資金提供がなければ加盟国に多額の負担金を強いることになるため、事態の改善には至っていない。
また、製薬企業連盟にとってもBSAAに出資していることは業界全体の姿勢をアピールする上で重要と考えられているため、この関係は当分の間続くとみられている。
最後に、BSAA結成当初から所属していた11名は、隊内では敬意を持って「オリジナル·イレブン」と呼ばれている。これは、アメリカのマーキュリー計画で選抜された7名の宇宙飛行士がオリジナル-セブンと呼ばれたことに由来している。オリジナル·イレブンの中にはクリス·レッドフィールドも含まれており、現在も数名の隊員が同隊で活躍中である。
Official English Transcript
"Due to errors or changes in localization, the following may contain inconsistencies with the official Japanese text."
BSAA
Following the annihilation of Raccoon City, Umbrella was hit hard with multiple lawsuits for their involvement in the incident. But there was an organization that was hit even harder by the fallout of that incident: the Global Pharmaceutical Consortium, an organization comprised of pharmaceutical companies from around the world.
Umbrella's development of and experimentation with Bio Organic Weapons (B.O.W.), along with the sale of those weapons on the black market, caused people to distrust the Global Pharmaceutical Consortium, and the fact that Umbrella was an executive board member only deepened their misgivings.
If things had ended there, the consortium may have just escaped with a tarnished reputation. But in today's world, medicine is an integral part of almost all medical procedures. The public is also quite informed when it comes to which medications are trusted and which are not. If the population looses trust in the pharmaceutical company responsible for creating certain medications, it can quickly bankrupt said company.
The Umbrella trials took a turn for the worse for the consortium when prosecutors presented evidence that incriminated many other pharmaceutical companies.
Prosecutors showed that Umbrella acquired medicines and techniques developed by other companies and employed them in their own bioweapons research. They commissioned each of the respective companies to only partially develop certain medications so that they could not be traced to what was ultimately being developed. The responsible companies thus unwittingly contributed to the development of bioweapons.
Until this development in the case, the consortium looked at the lawsuits as Umbrella's problem. Now the problem was thrust into their laps as well.
The companies that were linked to Umbrella faced the possibility of sharing blame for the deaths of hundreds of thousands of innocent people, and if Umbrella lost the lawsuits, they would face bankruptcy as well. Even if Umbrella was found not guilty of any wrongdoing, the negative publicity would not only be disastrous for sales, but the governments of the world would revoke the companies' permits to sell their products.
Not having permission to distribute their products worldwide would effectively dismantle their businesses.
The pharmaceutical companies realized they had no choice but to take drastic measures to counter their dismal prospects.
The consortium decided to strike a deal with the prosecutors. They would put all their efforts into assisting with the case against Umbrella, even to the point of turning over any internal company documentation. The prosecutors in the case, being obsessed with seeing Umbrella fall, agreed to accept the help of the consortium's companies, and in return they would not pursue legal action against them.
In 2003, Umbrella was found guilty on all charges. With its fall, the scandal that rocked the pharmaceutical industry to its core could finally be put to rest.
But Umbrella's dismantlement led to an unforeseen situation.
In the fallout of Umbrella's collapse, B.O.W.s began to show up on the black market. The weapons wound up in the hands of terrorists, guerrilla fighters, and unstable state governments. Soon the threat of these B.O.W.s began to be felt around the world.
Faced with a new Umbrella-like crisis, the Global Pharmaceutical Consortium knew they would have to take immediate action.
It was then that the Bioterrorism Security Assessment Alliance (BSAA) was formed to fight threats from B.O.W.s.
Upon its initial foundation, only eleven elite individuals were made part of the BSAA. Their job was limited to that of observers to armies and police units around the world that conducted counter-bioterrorism operations. Unfortunately, the world's bioterrorism problem was much bigger than anyone had anticipated, and so a new course of action was required to handle the problem.
To that end, consideration was given to creating a team that could react instantly to threats, but the BSAA was still only a civilian-led organization. They could not operate freely in sovereign nations, and thus were unable to conduct investigations, make pertinent arrests, or even use force when the situation dictated it. It was clear now that the threat of bioterrorism was now the entire world's problem, and something would have to be done.
The BSAA was then reformed under the U.N.'s jurisdiction.
As a U.N.-controlled special forces team, the BSAA's acceptance by the U.N.'s member states was taken as a given.
The truth of the matter was that only 70 percent of the member states would approve of BSAA activities on their soil, and the remainder of the states would only approve BSAA activities in their countries on a conditional basis.
That is how the current incarnation of the BSAA was formed.
The BSAA's headquarters was located in England, but any further details of the location were not released to the public. Since a BSAA team had to be able to be deployed within 12 hours, it was assumed that they were located near airport hub or an air force base. Some courses claimed that the BSAA had bases in the area under their jurisdiction.
The following is a list of areas under the jurisdiction of their respective BSAA branches.
European Headquarters: Europe and western Russia
Middle East Branch: The Middle of East and part of Africa
North American Branch: The entire North American continent (Chris Redfield and Jill Valentine are stationed here)
South American Branch: The entire South American continent
West African Branch: The western part of the African continent (Sheva Alomar is stationed here)
East African Branch: The eastern part of the African continent
Far East Branch: Eastern Russia and the countries east of India
Oceanian Branch: Australia is the center of operations of Oceania
(Antarctica, where Umbrella's Antarctic Base was located, falls under the jurisdiction of the Oceanian Branch.)
Each BSAA branch had a considerable number of people on their tactical teams, most of them coming from police special forces and militaries around the world.
The support staff for the teams was also quite large, and they came mainly from government organizations in different countries. There were many groups of experts on the staff that provided technical, medical, physical, and mental support to the teams.
The BSAA deployment teams were divided into two groups.
The first group was the Special Operations Unit (SOU). The SOU were sanctioned to infiltrate an area, engage in combat, and subdue offenders. Teams were usually comprised of 12 members, and each team was divided into three four-man cells.
A special feature of the SOU is the flexibility of its personnel during operations. In order to match the scale of an operation, cells from other teams are brought in on a regular basis. For one specific joint operation, there were 70 elite members working together.
Dan DeChant is currently the leader of Alpha Team for this operation. The team is comprised of his own standard team along with cells from other teams. (The designation Alpha Team will only be used for this operation.)
Reports indicate that because unknown B.O.W.s are involved, the efficacy of the tactical team's methods for handling them may be low, and consideration has to be given to the strong points that raise their efficacy.
Another key part of the BSAA is the Special Operations Agent (SOA). Usually they are referred to as just "agents", and unlike the SOU, agents work alone. The agents are primarily involved in investigations and espionage activities, and as such, they are considered the eyes and ears for the BSAA. During certain operations, it may become difficult for tactical teams to penetrate to the front, so it is up to the agents to carry out the missions.
During those types of missions, a two-man cell is the basic deployment unit required to carry out the mission.
Sometimes agents must go beyond the jurisdiction of a BSAA branch to carry out their missions. Many of them are dispatched to areas with unlawful activities. This mission sees agent Chris Redfield in that role.
Agents who work alone are highly capable, and they rank higher than SOU members; however, agents are not chosen so much for their abilities or technical prowess, but for the psychological state and aptitude in handling situations. In actual skills and abilities, they may be outperformed by SOU members.
The BSAA is a public organization with an international staff, but owing to the logistics of running such an organization, it is a well-known fact that most of their funding comes from the Global Pharmaceutical Consortium.
While this relationship has been the target of much criticism, the consortium's funding removes the financial burden from participatory nations, and as such, any motivation to change the situation and incur unwanted expenses. As for the consortium, their sponsorship acts as much needed industry-wide PR service. So far this partnership has been beneficial to all parties involved.
On a final note, the eleven members who were part of the BSAA from the beginning are highly respected within the organization, and are known as the Original Eleven. The name comes from the Original Seven, who were the seven astronauts selects for Project Mercury.
Two of these Original Eleven are Chris Redfield and Jill Valentine. A number of other members of the Original Eleven also work alongside many of the tactical teams.
BSAA
Following the annihilation of Raccoon City, Umbrella was hit hard with multiple lawsuits for their involvement in the incident. But there was an organization that was hit even harder by the fallout of that incident: the Global Pharmaceutical Consortium, an organization comprised of pharmaceutical companies from around the world.
Umbrella's development of and experimentation with Bio Organic Weapons (B.O.W.), along with the sale of those weapons on the black market, caused people to distrust the Global Pharmaceutical Consortium, and the fact that Umbrella was an executive board member only deepened their misgivings.
If things had ended there, the consortium may have just escaped with a tarnished reputation. But in today's world, medicine is an integral part of almost all medical procedures. The public is also quite informed when it comes to which medications are trusted and which are not. If the population looses trust in the pharmaceutical company responsible for creating certain medications, it can quickly bankrupt said company.
The Umbrella trials took a turn for the worse for the consortium when prosecutors presented evidence that incriminated many other pharmaceutical companies.
Prosecutors showed that Umbrella acquired medicines and techniques developed by other companies and employed them in their own bioweapons research. They commissioned each of the respective companies to only partially develop certain medications so that they could not be traced to what was ultimately being developed. The responsible companies thus unwittingly contributed to the development of bioweapons.
Until this development in the case, the consortium looked at the lawsuits as Umbrella's problem. Now the problem was thrust into their laps as well.
The companies that were linked to Umbrella faced the possibility of sharing blame for the deaths of hundreds of thousands of innocent people, and if Umbrella lost the lawsuits, they would face bankruptcy as well. Even if Umbrella was found not guilty of any wrongdoing, the negative publicity would not only be disastrous for sales, but the governments of the world would revoke the companies' permits to sell their products.
Not having permission to distribute their products worldwide would effectively dismantle their businesses.
The pharmaceutical companies realized they had no choice but to take drastic measures to counter their dismal prospects.
The consortium decided to strike a deal with the prosecutors. They would put all their efforts into assisting with the case against Umbrella, even to the point of turning over any internal company documentation. The prosecutors in the case, being obsessed with seeing Umbrella fall, agreed to accept the help of the consortium's companies, and in return they would not pursue legal action against them.
In 2003, Umbrella was found guilty on all charges. With its fall, the scandal that rocked the pharmaceutical industry to its core could finally be put to rest.
But Umbrella's dismantlement led to an unforeseen situation.
In the fallout of Umbrella's collapse, B.O.W.s began to show up on the black market. The weapons wound up in the hands of terrorists, guerrilla fighters, and unstable state governments. Soon the threat of these B.O.W.s began to be felt around the world.
Faced with a new Umbrella-like crisis, the Global Pharmaceutical Consortium knew they would have to take immediate action.
It was then that the Bioterrorism Security Assessment Alliance (BSAA) was formed to fight threats from B.O.W.s.
Upon its initial foundation, only eleven elite individuals were made part of the BSAA. Their job was limited to that of observers to armies and police units around the world that conducted counter-bioterrorism operations. Unfortunately, the world's bioterrorism problem was much bigger than anyone had anticipated, and so a new course of action was required to handle the problem.
To that end, consideration was given to creating a team that could react instantly to threats, but the BSAA was still only a civilian-led organization. They could not operate freely in sovereign nations, and thus were unable to conduct investigations, make pertinent arrests, or even use force when the situation dictated it. It was clear now that the threat of bioterrorism was now the entire world's problem, and something would have to be done.
The BSAA was then reformed under the U.N.'s jurisdiction.
As a U.N.-controlled special forces team, the BSAA's acceptance by the U.N.'s member states was taken as a given.
The truth of the matter was that only 70 percent of the member states would approve of BSAA activities on their soil, and the remainder of the states would only approve BSAA activities in their countries on a conditional basis.
That is how the current incarnation of the BSAA was formed.
The BSAA's headquarters was located in England, but any further details of the location were not released to the public. Since a BSAA team had to be able to be deployed within 12 hours, it was assumed that they were located near airport hub or an air force base. Some courses claimed that the BSAA had bases in the area under their jurisdiction.
The following is a list of areas under the jurisdiction of their respective BSAA branches.
European Headquarters: Europe and western Russia
Middle East Branch: The Middle of East and part of Africa
North American Branch: The entire North American continent (Chris Redfield and Jill Valentine are stationed here)
South American Branch: The entire South American continent
West African Branch: The western part of the African continent (Sheva Alomar is stationed here)
East African Branch: The eastern part of the African continent
Far East Branch: Eastern Russia and the countries east of India
Oceanian Branch: Australia is the center of operations of Oceania
(Antarctica, where Umbrella's Antarctic Base was located, falls under the jurisdiction of the Oceanian Branch.)
Each BSAA branch had a considerable number of people on their tactical teams, most of them coming from police special forces and militaries around the world.
The support staff for the teams was also quite large, and they came mainly from government organizations in different countries. There were many groups of experts on the staff that provided technical, medical, physical, and mental support to the teams.
The BSAA deployment teams were divided into two groups.
The first group was the Special Operations Unit (SOU). The SOU were sanctioned to infiltrate an area, engage in combat, and subdue offenders. Teams were usually comprised of 12 members, and each team was divided into three four-man cells.
A special feature of the SOU is the flexibility of its personnel during operations. In order to match the scale of an operation, cells from other teams are brought in on a regular basis. For one specific joint operation, there were 70 elite members working together.
Dan DeChant is currently the leader of Alpha Team for this operation. The team is comprised of his own standard team along with cells from other teams. (The designation Alpha Team will only be used for this operation.)
Reports indicate that because unknown B.O.W.s are involved, the efficacy of the tactical team's methods for handling them may be low, and consideration has to be given to the strong points that raise their efficacy.
Another key part of the BSAA is the Special Operations Agent (SOA). Usually they are referred to as just "agents", and unlike the SOU, agents work alone. The agents are primarily involved in investigations and espionage activities, and as such, they are considered the eyes and ears for the BSAA. During certain operations, it may become difficult for tactical teams to penetrate to the front, so it is up to the agents to carry out the missions.
During those types of missions, a two-man cell is the basic deployment unit required to carry out the mission.
Sometimes agents must go beyond the jurisdiction of a BSAA branch to carry out their missions. Many of them are dispatched to areas with unlawful activities. This mission sees agent Chris Redfield in that role.
Agents who work alone are highly capable, and they rank higher than SOU members; however, agents are not chosen so much for their abilities or technical prowess, but for the psychological state and aptitude in handling situations. In actual skills and abilities, they may be outperformed by SOU members.
The BSAA is a public organization with an international staff, but owing to the logistics of running such an organization, it is a well-known fact that most of their funding comes from the Global Pharmaceutical Consortium.
While this relationship has been the target of much criticism, the consortium's funding removes the financial burden from participatory nations, and as such, any motivation to change the situation and incur unwanted expenses. As for the consortium, their sponsorship acts as much needed industry-wide PR service. So far this partnership has been beneficial to all parties involved.
On a final note, the eleven members who were part of the BSAA from the beginning are highly respected within the organization, and are known as the Original Eleven. The name comes from the Original Seven, who were the seven astronauts selects for Project Mercury.
Two of these Original Eleven are Chris Redfield and Jill Valentine. A number of other members of the Original Eleven also work alongside many of the tactical teams.